Physician profile
Eric S Kramer
NPI 1750470886
$2,817.99
in general payments reported to CMS, 2019-2025
15 companies · $847 in 2025
The $847 reported for 2025 was more than what 79% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.81 · 2020: $11.71 · 2021: $95.20 · 2022: $49.17 · 2023: $682 · 2024: $1,088 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,617.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $681.44 | 2023-2025 | Spravato, Invega |
| Alkermes, INC. | $632.63 | 2020-2025 | Aristada, Lybalvi, Vivitrol |
| Teva Pharmaceuticals USA, INC. | $339.21 | 2019-2025 | Uzedy, Austedo Xr |
| Neurocrine Biosciences, INC. | $252.52 | 2023-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $215.15 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Lundbeck LLC | $180.76 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Abbvie INC. | $163.85 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $77.19 | 2021-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $66.34 | 2025 | Fanapt |
| Axsome Therapeutics, INC. | $63.69 | 2024-2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $50.09 | 2024-2025 | Cobenfy |
| Indivior INC. | $45.17 | 2024 | Perseris |
| Allergan, INC. | $16.96 | 2019 | |
| Sunovion Pharmaceuticals INC. | $16.59 | 2019 | |
| Biogen, INC. | $16.40 | 2025 | Leqembi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.